Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US

 Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US

Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US

Shots:

  • Abbott has launched the IonicRF Generator, which is used to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system
  • Radiofrequency ablation uses an electric current to heat up a small area of nerve tissue to stop it from sending pain signals. Studies showed that pain relief following a single radiofrequency ablation treatment can last from 6-12mos.
  • The IonicRF generator is the first Abbott-developed radiofrequency ablation device that uses heat to target specific nerves & block pain signals from reaching the brain, currently approved in the US & EU

Click here ­to­ read full press release/ article | Ref: Abbott | Image: Abbott Neuromodulation

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post